Related Experiment Videos
Comparative mobilization of lead by chelating agents
1Department of Public Health, China Medical University, Shenyang, People's Republic of China.
Toxicology
|December 30, 1988
Summary
This study evaluated chelating agents for lead poisoning in mice, finding meso-2,3-dimercaptosuccinic acid (DMSA) and others effective in reducing lead levels in organs and tissues.
Area of Science:
- Toxicology
- Pharmacology
- Environmental Health
Background:
- Lead poisoning poses significant health risks.
- Chelating agents are used to treat heavy metal toxicity.
- Understanding agent efficacy is crucial for treatment strategies.
Purpose of the Study:
- To compare the effectiveness of approximately 20 chelating agents in treating acute and chronic lead poisoning in mice.
- To determine the LD50 of lead acetate trihydrate in mice.
- To assess the impact of chelating agents on lead distribution in various organs.
Main Methods:
- Acute toxicity testing to determine LD50 for lead acetate trihydrate.
- Administration of various chelating agents to lead-poisoned mice.
- Quantification of lead levels in liver, kidney, spleen, bone, and brain tissues.
Main Results:
- The acute LD50 for lead acetate trihydrate was 135.3 mg Pb/kg.
- Meso-2,3-dimercaptosuccinic acid (DMSA), DPMS, Na2CaEDTA, and BAL were among the most effective chelating agents.
- Significant lead redistribution from liver to bone occurred within the first 7 days post-injection.
Conclusions:
- Several chelating agents demonstrate significant efficacy in mobilizing lead from tissues.
- DMSA and DPMS show promise for treating lead poisoning.
- Lead dynamics in organs are complex and change rapidly post-exposure.